SEC Filing Summary: Form 6-K
Business Context and Reporting Period
This Form 6-K is filed by Galapagos NV, a foreign private issuer, for the month of December 2020. The filing date is December 15, 2020. The document serves to incorporate by reference a press release (Exhibit 99.1) issued on the same date. The registrant's principal executive office is located in Mechelen, Belgium. Note: The request metadata references "Lakefront Biotherapeutics NV," but the filing text explicitly identifies the registrant as Galapagos NV.
Financial Metrics
The filing text does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing to distribute a press release and does not contain a financial statement or quarterly results summary.
Material Changes
The filing does not disclose material changes in financial position or operations within the text provided. The primary content is the incorporation of an external press release, the details of which are not included in the source text.
Guidance, Outlook, and Risks
Management commentary, guidance, outlook, risks, and contingencies are not detailed in the provided text. The filing notes that specific quotes from Daniel O'Day and Onno van de Stolpe contained in the attached press release are excluded from incorporation by reference into the Company's Registration Statements.
Key Facts for Investor Verification
- Registrant Identity: Verify that the filing pertains to Galapagos NV, not Lakefront Biotherapeutics NV as suggested in the metadata.
- Press Release Content: The substantive information is located in Exhibit 99.1 (the press release), which is not included in the provided text.
- Incorporation by Reference: The press release is incorporated into multiple Registration Statements (Forms F-3 and S-8), except for specific executive quotes.
- Reporting Status: The company files annual reports under Form 20-F.